These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33882539)

  • 1. Bone Metabolism in the Healing Process of Lumbar Interbody Fusion: Temporal Changes of Bone Turnover Markers.
    Hyakkan R; Kanayama M; Takahata M; Oha F; Hashimoto T; Iwasaki N
    Spine (Phila Pa 1976); 2021 Dec; 46(23):1645-1652. PubMed ID: 33882539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in bone turnover markers after discontinuing long-term glucocorticoid administration in children with idiopathic nephrotic syndrome: a multicenter retrospective observational study.
    Ueda Y; Okamoto T; Sato Y; Hayashi A; Takahashi T; Suzuki R; Aoyagi H; Ueno M; Kobayashi N; Uetake K; Nakanishi M; Ariga T; Manabe A
    Pediatr Nephrol; 2023 Oct; 38(10):3285-3296. PubMed ID: 37052692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Turnover Markers as a New Predicting Factor for Nonunion After Spinal Fusion Surgery.
    Inose H; Yamada T; Mulati M; Hirai T; Ushio S; Yoshii T; Kato T; Kawabata S; Okawa A
    Spine (Phila Pa 1976); 2018 Jan; 43(1):E29-E34. PubMed ID: 27879570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRACP-5b/BAP Score After 3 Months of Treatment With Combined SERM/E2 Therapy Can Predict Changes in Lumbar Spine Bone Mineral Density After 1 Year of Treatment in Early Postmenopausal Osteopenia.
    Ota I; Ota Y; Ota K; Eda H; Ohta H
    JBMR Plus; 2022 Nov; 6(11):e10690. PubMed ID: 36398113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis.
    Vasikaran SD; Miura M; Pikner R; Bhattoa HP; Cavalier E;
    Calcif Tissue Int; 2023 Feb; 112(2):148-157. PubMed ID: 34846540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation.
    Kurosawa S; Doki N; Senoo Y; Kishida Y; Nagata A; Yamada Y; Konishi T; Kaito S; Yoshifuji K; Matsuyama N; Shirane S; Uchida T; Inamoto K; Toya T; Igarashi A; Najima Y; Muto H; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Ann Hematol; 2020 Aug; 99(8):1873-1882. PubMed ID: 32451708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRACP 5b and CTX as osteological markers of delayed fracture healing.
    Moghaddam A; Müller U; Roth HJ; Wentzensen A; Grützner PA; Zimmermann G
    Injury; 2011 Aug; 42(8):758-64. PubMed ID: 21168135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of bone turnover markers after elderly hip fracture surgery.
    Li XP; Li XY; Yang MH; Zhu SW; Wu XB; Zhang P
    J Bone Miner Metab; 2021 Mar; 39(2):237-244. PubMed ID: 32876727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients.
    Iizuka Y; Iizuka H; Kaneko T; Mieda T; Takechi R; Suzuki H; Sorimachi Y; Suto T; Tachibana M; Yoneyama T; Omodaka T; Hashimoto S; Hamano N; Sakane H; Shimoyama D; Kohama I; Ohshima A; Nozaki T; Kamiyama M; Moteki T; Ohshima A; Takamine S; Honda A; Ueno A; Tajika T; Okamura K; Warita T; Yonemoto Y; Shitara H; Ohsawa T; Takagishi K
    Injury; 2016 Nov; 47(11):2484-2489. PubMed ID: 27670281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y; Liu X; Xu H
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
    Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C
    Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.
    Gossiel F; Ugur A; Peel NFA; Walsh JS; Eastell R
    Osteoporos Int; 2022 Jun; 33(6):1357-1363. PubMed ID: 35102444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
    Nakatoh S
    J Bone Miner Metab; 2018 Mar; 36(2):221-228. PubMed ID: 28293779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients.
    Hori M; Yasuda K; Takahashi H; Kondo C; Shirasawa Y; Ishimaru Y; Sekiya Y; Morozumi K; Maruyama S
    Sci Rep; 2022 May; 12(1):7781. PubMed ID: 35546172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
    Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
    Mawatari T; Ikemura S; Matsui G; Iguchi T; Mitsuyasu H; Kawahara S; Maehara M; Muraoka R; Iwamoto Y; Nakashima Y
    Bone Rep; 2020 Jun; 12():100275. PubMed ID: 32462056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Bone Metabolism with Fatty Liver Disease in the Elderly in Japan: A Community-based Study.
    Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Sawada K; Nakaji S; Ishibashi Y; Matsuzaka M; Fukuda S
    Intern Med; 2020 May; 59(10):1247-1256. PubMed ID: 32101831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.
    Marques EA; Gudnason V; Sigurdsson G; Lang T; Johannesdottir F; Siggeirsdottir K; Launer L; Eiriksdottir G; Harris TB
    Osteoporos Int; 2016 May; 27(5):1765-76. PubMed ID: 26630978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2009 Aug; 19(8):1075-82. PubMed ID: 19638690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.